ADC Therapeutics SA (ADCT)
1.10
+0.12
(+12.51%)
USD |
NYSE |
Jun 09, 16:00
1.09
-0.01
(-0.91%)
Pre-Market: 06:00
ADC Therapeutics SG&A Expense (Quarterly) : 22.60M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 556.75M |
| AC Immune SA | 5.326M |
| CRISPR Therapeutics AG | 17.18M |
| Idorsia Ltd. | 77.58M |
| MoonLake Immunotherapeutics | 15.51M |